Breaking News Instant updates and real-time market news.

GERN

Geron

$1.34

-0.02 (-1.48%)

16:23
09/30/19
09/30
16:23
09/30/19
16:23

FDA grants Geron's imetelstat Fast Track designation in MF treatment

Geron announced that the FDA has granted Fast Track designation to imetelstat for the treatment of adult patients with Intermediate-2 or High-risk myelofibrosis, or MF, whose disease has relapsed after or is refractory to janus kinase inhibitor treatment, or relapsed/refractory MF. The Fast Track designation includes patients with primary MF and MF developed after essential thrombocythemia or polycythemia vera. This is the same patient population that was studied in Geron's IMbark Phase 2 clinical trial. There are currently no marketed drugs specifically approved for relapsed/refractory MF, representing a significant unmet medical need. Geron plans to conduct an End of Phase 2 meeting with the FDA by the end of the first quarter of 2020 to determine if there is a regulatory path forward for imetelstat in relapsed/refractory MF.

  • 02

    Oct

GERN Geron
$1.34

-0.02 (-1.48%)

04/09/19
04/09/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Outperform from Market Perform at Cowen with analyst Doug Creutz saying he views Disney's "catalyst path for the next year as highly attractive" and believes Thursday's investor day will likely be a "deck-clearing event for sentiment." 2. Comcast (CMCSA) upgraded to Outperform from Neutral at Macquarie with analyst Amy Young saying she remains bullish on pure-play Altice and efforts across Sky, Xfinity, and NBCU. 3. Geron (GERN) upgraded to Buy from Hold at Needham with analyst Chad Messer saying the return of development rights for imetelstat in September by Janssen (JNJ) has created a "buying opportunity." 4. Public Storage (PSA) upgraded to Hold from Underperform at Jefferies with analyst Omotayo Okusanya saying with interest rates set to be lower for longer, equity risk premiums have dropped. 5. PerkinElmer (PKI) upgraded to Conviction Buy from Neutral at Goldman Sachs with analyst Patrick Donnelly saying the continuation of the company's growth acceleration should exceed "conservative" expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/28/19
RILY
06/28/19
NO CHANGE
Target $4.5
RILY
Buy
Geron price target raised to $4.50 from $3.25 at B. Riley FBR
B. Riley FBR analyst George Zavoico raised his price target for Geron to $4.50 from $3.25 after the company recently presented new results from its two trials of imetelstat in two different blood cancers. The results provide "strong evidence" of safety and efficacy that is "markedly superior" to current standard of care, Zavoico tells investors in a research note. He keeps a Buy rating on Geron.
08/15/19
CANT
08/15/19
INITIATION
Target $4
CANT
Overweight
Geron initiated with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan started Geron with an Overweight rating and $4 price target. Geron's "first-in-class" telomerase inhibitor imetelstat leverages a novel drug target to address myelodysplastic syndrome and myeloproliferative neoplasms, Duncan tells investors in a research note. The analyst views the company's shares as undervalued.
09/03/19
HCWC
09/03/19
INITIATION
Target $4
HCWC
Buy
Geron initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Vernon Bernardino started Geron with a Buy rating and $4 price target. The analyst says he's bullish on the shares based on the return of global rights to imetelstat from Janssen, which he thinks has the potential to result in higher returns, the potential of imetelstat to decrease red blood cell transfusion dependence in patients suffering with low- or intermediate-1 risk myelodysplastic syndromes, and the potential of imetelstat to have a disease-modifying effect in patients suffering with myelofibrosis. Geron's potential for increased returns from full global rights to imetelstat is underappreciated by investors, Bernardino tells investors in a research note.

TODAY'S FREE FLY STORIES

SG

Sirius International Insurance Group

$7.75

0.4 (5.44%)

15:50
11/13/19
11/13
15:50
11/13/19
15:50
Periodicals
Sirius International 'pitched for sale,' Insurance Insider reports »

Sirius International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRWD

Crowdstrike

$51.35

4.34 (9.23%)

15:45
11/13/19
11/13
15:45
11/13/19
15:45
Options
CrowdStrike Holdings call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

QGEN

Qiagen

$32.98

0.72 (2.23%)

, TMO

Thermo Fisher

$298.97

2.89 (0.98%)

15:43
11/13/19
11/13
15:43
11/13/19
15:43
Hot Stocks
Qiagen shares surge as Thermo Fisher reportedly weighs purchase »

Shares of Qiagen (QGEN)…

QGEN

Qiagen

$32.98

0.72 (2.23%)

TMO

Thermo Fisher

$298.97

2.89 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 07

    Dec

QGEN

Qiagen

$33.09

0.83 (2.57%)

15:39
11/13/19
11/13
15:39
11/13/19
15:39
Hot Stocks
Breaking Hot Stocks news story on Qiagen 

Qiagen trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CTAS

Cintas

$254.89

-4.01 (-1.55%)

15:38
11/13/19
11/13
15:38
11/13/19
15:38
Recommendations
Cintas analyst commentary  »

Cintas management offers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$298.79

2.71 (0.92%)

, QGEN

Qiagen

$33.03

0.77 (2.39%)

15:35
11/13/19
11/13
15:35
11/13/19
15:35
Periodicals
Thermo Fisher considering purchase of Qiagen, Bloomberg reports »

Thermo Fisher has…

TMO

Thermo Fisher

$298.79

2.71 (0.92%)

QGEN

Qiagen

$33.03

0.77 (2.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 07

    Dec

QGEN

Qiagen

$33.03

0.77 (2.39%)

15:34
11/13/19
11/13
15:34
11/13/19
15:34
Hot Stocks
Breaking Hot Stocks news story on Qiagen »

Qiagen trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

PUMP

ProPetro Holding

$7.49

-0.21 (-2.73%)

15:34
11/13/19
11/13
15:34
11/13/19
15:34
Options
ProPetro Holding options imply 26.4% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PTON

Peloton

$24.60

-0.12 (-0.49%)

15:21
11/13/19
11/13
15:21
11/13/19
15:21
Periodicals
Peloton said to plan cheaper treadmill, rowing machine for 2020, Bloomberg says »

Peloton (PTON) is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 09

    Dec

TNK

Teekay Tankers

$2.02

-0.055 (-2.66%)

15:19
11/13/19
11/13
15:19
11/13/19
15:19
Options
Teekay Tankers options imply 19.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
11/13/19
11/13
15:17
11/13/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
11/13/19
11/13
15:16
11/13/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$147.12

8.56 (6.18%)

, NFLX

Netflix

$284.22

-7.79 (-2.67%)

15:04
11/13/19
11/13
15:04
11/13/19
15:04
On The Fly
Disney higher as Disney+ streaming service hits 10M subscribers after one day »

On Tuesday morning, The…

DIS

Disney

$147.12

8.56 (6.18%)

NFLX

Netflix

$284.22

-7.79 (-2.67%)

AAPL

Apple

$264.03

2.14 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 09

    Dec

  • 10

    Dec

NTAP

NetApp

$60.15

0.03 (0.05%)

15:04
11/13/19
11/13
15:04
11/13/19
15:04
Options
NetApp options imply 14.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 20

    Nov

  • 12

    Dec

PDLB

PDL Community Bancorp

$13.78

-0.21 (-1.50%)

15:01
11/13/19
11/13
15:01
11/13/19
15:01
Hot Stocks
PDL Community Bancorp to repurchase up to 878,835 shares of common stock »

PDL Community Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRK

Comstock Resources

$6.86

-0.02 (-0.29%)

, CHK

Chesapeake

$0.70

0.0303 (4.52%)

14:56
11/13/19
11/13
14:56
11/13/19
14:56
Periodicals
Jerry Jones confirms to Bloomberg that Comstock in talks for Chesapeake assets »

Comstock Resources'…

CRK

Comstock Resources

$6.86

-0.02 (-0.29%)

CHK

Chesapeake

$0.70

0.0303 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INST

Instructure

$50.73

2.75 (5.73%)

14:55
11/13/19
11/13
14:55
11/13/19
14:55
Periodicals
Instructure exploring sale following activist pressure, Bloomberg says »

Instructure is weighing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 09

    Dec

ILMN

Illumina

$297.27

1.39 (0.47%)

14:55
11/13/19
11/13
14:55
11/13/19
14:55
Conference/Events
Illumina participates in a conference call with SVB Leerink »

Conference call with Dr.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$48.52

0.14 (0.29%)

14:49
11/13/19
11/13
14:49
11/13/19
14:49
Options
Cisco options imply 7.1% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 09

    Dec

  • 10

    Dec

LPSN

LivePerson

$34.88

-0.29 (-0.82%)

14:48
11/13/19
11/13
14:48
11/13/19
14:48
Conference/Events
LivePerson management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 10

    Dec

ESTA

Establishment Labs

$23.77

0.17 (0.72%)

14:46
11/13/19
11/13
14:46
11/13/19
14:46
Conference/Events
Establishment Labs management to meet with Jefferies »

Meetings to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

CLDR

Cloudera

$8.47

-0.195 (-2.25%)

14:45
11/13/19
11/13
14:45
11/13/19
14:45
Options
Cloudera call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

DIS

Disney

$145.75

7.19 (5.19%)

14:41
11/13/19
11/13
14:41
11/13/19
14:41
Recommendations
Disney analyst commentary  »

Disney price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$145.31

6.75 (4.87%)

14:38
11/13/19
11/13
14:38
11/13/19
14:38
Hot Stocks
Disney confirms 10M sign-ups for Disney+ since yesterday's launch »

Disney+, the streaming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
11/13/19
11/13
14:35
11/13/19
14:35
General news
Fedspeak continues Thursday, headlined by Chair Powell »

Fedspeak continues…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.